RC is not a good buy right now for a beginner long-term investor, especially with $50,000-$100,000 to deploy. The stock is trading in a weak technical setup, analyst sentiment remains negative, there is no recent news catalyst, and there are no strong proprietary buy signals. Based on the data, the better decision is to avoid buying now.
Current pre-market price is 1.72, just below pivot resistance near 1.729. Momentum is weak: MACD histogram is negative and still contracting, RSI_6 is neutral at 49.4, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. This shows a downtrend or at best a fragile consolidation, not a strong entry setup. Key support is 1.599 and resistance is 1.859. The stock trend model also suggests mixed-to-weak near-term performance, with a 30% chance of -2.07% the next day and only modest medium-term upside probability.

No news in the recent week, so there are no clear event-driven catalysts. The only mild positive is that options flow today shows much heavier call volume than put volume, and pre-market trading is slightly positive at 1.72.
Keefe Bruyette cut its price target twice recently and keeps an Underperform rating. Technicals are bearish, the market is pre-market while S&P 500 is down 0.64%, and there is no recent positive news. Hedge funds and insiders are neutral, so there is no supportive buying trend from influential holders. No congress trading activity is available. The financial snapshot is unavailable, which removes a key fundamental support case.
Latest quarter financials were not provided due to an error in the snapshot, so there is no usable revenue, earnings, or growth data to support a buy decision. Because this is a long-term beginner-focused decision, the absence of verified quarter-over-quarter growth data is a negative in itself.
Analyst sentiment is bearish. Keefe Bruyette lowered the price target from 1.85 to 1.60 on 2026-04-08 and again lowered it to 1.40 on 2026-05-11, while keeping an Underperform rating both times. This is a clear negative trend in both target and recommendation. Wall Street pros are leaning against the stock rather than supporting it.